```html

Oophorectomy (Surgical Removal of Ovaries) – A Complete Patient Guide

Overview

Oophorectomy is the surgical removal of one or both ovaries. The procedure may be performed unilateral (one ovary) or bilateral (both ovaries) and can be done via an abdominal incision (laparotomy), minimally invasive laparoscopy, or robotic‑assisted surgery.

• Who it affects: Primarily women of reproductive age who have ovarian tumors, endometriosis, or genetic conditions that increase cancer risk. It is also performed in post‑menopausal women for hormone‑related conditions or as part of a hysterectomy.
• Prevalence: In the United States, ~150,000 oophorectomies are performed each year, with >80 % being bilateral and often done concurrently with a hysterectomy [CDC, 2023].
• Why it matters: The ovaries produce estrogen, progesterone, and androgens; removal triggers surgical menopause, which has short‑ and long‑term health implications.

Symptoms

Because oophorectomy eliminates ovarian function, patients experience a range of symptoms—both immediate post‑operative and long‑term hormonal changes. Common manifestations include:

Immediate/Post‑operative Symptoms

• Pain or pressure at the incision site – dull to sharp pain that usually improves within 1–2 weeks.
• Abdominal bloating or gas – related to anesthesia and reduced bowel motility.
• Nausea or vomiting – common after any abdominal surgery.
• Fatigue – due to anesthesia, tissue healing, and beginning hormonal shifts.

Short‑Term Hormonal Symptoms (Weeks to months)

• Hot flashes and night sweats – sudden warmth, flushing, and sweating.
• Vaginal dryness – reduced lubrication leading to discomfort during intercourse.
• Mood changes – irritability, anxiety, or mild depression.
• Sleep disturbances – difficulty falling or staying asleep.
• Decreased libido – reduced sexual desire.
• Memory or concentration difficulties (“brain fog”).

Long‑Term Hormonal Symptoms (Months to years)

• Accelerated bone loss – increased risk of osteopenia/osteoporosis.
• Cardiovascular changes – higher LDL cholesterol, higher blood pressure.
• Urinary incontinence – loss of pelvic floor tone.
• Joint and muscle aches – estrogen deficiency affects connective tissue.
• Increased risk for cognitive decline – long‑term studies link early surgical menopause with earlier onset of dementia.

Causes and Risk Factors

Unlike many conditions, an oophorectomy is a treatment rather than a disease. The decision to remove ovaries is based on underlying pathology or risk reduction.

Medical Indications

• Ovarian cancer or malignant tumors – the most common reason for bilateral removal.
• Benign ovarian cysts or solid masses that are large, recurrent, or suspicious for cancer.
• Endometriosis – severe disease unresponsive to medication.
• Pelvic inflammatory disease (PID) with extensive adhesions.
• Genetic predisposition – carriers of BRCA1/2 or Lynch syndrome may elect prophylactic oophorectomy after childbearing.
• Severe pelvic pain unrelieved by conservative therapy.

Risk Factors for Requiring Oophorectomy

• Family history of ovarian or breast cancer.
• Known BRCA1/2 or other high‑penetrance DNA repair gene mutations.
• Personal history of breast cancer (especially estrogen‑receptor positive).
• Early onset of endometriosis or recurrent severe pelvic infections.
• Age >35 years when ovarian masses are discovered (higher malignancy risk).

Diagnosis

Accurate diagnosis informs whether removal is necessary and helps plan the surgical approach.

History and Physical Exam

• Detailed menstrual, sexual, and family‑history review.
• Pelvic exam to assess mass size, tenderness, and mobility.

Imaging Studies

• Transvaginal ultrasound – first‑line for cystic or solid ovarian lesions.
• Pelvic MRI or CT scan – provides detailed anatomy, especially for large masses or suspected malignancy.
• Doppler flow studies – help differentiate benign from malignant masses by evaluating blood flow patterns.

Laboratory Tests

• CA‑125 – tumor marker elevated in many ovarian cancers (not specific).
• HE4 – used with CA‑125 in the ROMA algorithm to assess cancer risk.
• Genetic testing – BRCA1/2, TP53, and other hereditary cancer panels when family history suggests.
• Complete blood count, electrolytes, and coagulation profile – baseline for surgery.

Pathology (when tissue is obtained)

• Frozen section intra‑operative pathology can guide extent of surgery.
• Final histopathology confirms benign vs malignant nature.

Treatment Options

While oophorectomy itself is a definitive treatment, the broader management plan includes pre‑operative preparation, the surgical technique, and post‑operative care.

Pre‑Operative Measures

• Stop smoking ≥6 weeks before surgery to lower wound‑healing complications.
• Discuss hormone‑replacement therapy (HRT) with a physician if pre‑menopausal.
• Baseline bone‑density scan (DEXA) if planning early menopause.
• Psychological counseling for fertility or identity concerns.

Surgical Approaches

• Laparoscopic/oophorectomy – 3–5 mm ports, less pain, faster recovery; preferred for most benign cases.
• Robotic‑assisted – enhanced dexterity, useful for complex masses.
• Laparotomy – large abdominal incision; reserved for suspected advanced cancer.
• Surgeon may combine with hysterectomy (removal of uterus) or lymph node sampling if cancer is present.

Post‑Operative Management

• Pain control – acetaminophen, NSAIDs, or short‑course opioids as needed.
• Antibiotic prophylaxis – single dose of a cephalosporin before incision.
• Early ambulation – reduces clot risk.
• Venous thromboembolism (VTE) prophylaxis – compression stockings or low‑dose heparin for high‑risk patients.
• Hormone replacement therapy (if not contraindicated) – transdermal estradiol ± progesterone to alleviate menopausal symptoms and protect bone health.

Non‑Surgical Alternatives (when appropriate)

• Watchful waiting with serial imaging for small, benign‑appearing cysts.
• Hormonal suppression (GnRH agonists) for severe endometriosis.
• Targeted therapy (e.g., PARP inhibitors) for BRCA‑mutated ovarian cancer – may avoid surgery in select metastatic cases.

Living with Oophorectomy (Surgical Removal of Ovaries)

Adjusting to life after ovary removal involves managing hormonal changes, protecting bone health, and monitoring cardiovascular risk.

Hormone Management

• Hormone replacement therapy – most women benefit from estrogen (transdermal preferred) until natural menopause age (~51 y). Add progesterone if the uterus remains.
• Discuss alternatives (e.g., phytoestrogens, selective estrogen receptor modulators) if HRT is contraindicated.

Bone Health

• Calcium 1,200 mg/day + Vitamin D 800‑1,000 IU/day.
• Weight‑bearing exercise (walking, resistance training) 3‑4 times/week.
• Dexa scan at baseline and every 2‑3 years; consider bisphosphonates if T‑score ≤ ‑2.5.

Cardiovascular Wellness

• Monitor blood pressure and lipid profile annually.
• Adopt a Mediterranean‑style diet rich in fruits, vegetables, whole grains, fish, and olive oil.
• Limit saturated fat, processed sugars, and smoking.

Mental & Emotional Health

• Join support groups for surgical menopause or prophylactic oophorectomy.
• Consider counseling if experiencing grief over fertility loss or identity changes.
• Mind‑body practices (yoga, meditation) can reduce hot‑flash frequency.

Sexual Health

• Use water‑based lubricants for vaginal dryness.
• Pelvic floor physical therapy improves tone and reduces dyspareunia.
• Open communication with partners about changes.

Fertility Considerations

• If only one ovary remains, natural conception is still possible; ovulation tracking may help.
• For bilateral oophorectomy, discuss egg or embryo cryopreservation **before** surgery if future pregnancy is desired.

Prevention

Because oophorectomy is usually performed for an existing condition, “prevention” focuses on reducing the risk of those underlying diseases.

• Maintain a healthy weight – obesity is linked to higher ovarian cancer risk.
• Use oral contraceptives for ≥5 years, which lower ovarian cancer risk by ~30 % (NIH, 2022).
• Regular gynecologic screening for women at high genetic risk (annually or per specialist recommendation).
• Genetic counseling for families with known BRCA or Lynch mutations; consider prophylactic surgery after childbearing.
• Limit talc use in the genital area – some studies suggest a modest increase in ovarian cancer risk.

Complications

Complications may arise from the surgery itself or from the hormonal changes that follow.

Surgical Complications

• Bleeding or hematoma.
• Infection of the incision or pelvic cavity.
• Injury to surrounding structures (bladder, ureter, bowel).
• Adhesion formation leading to chronic pelvic pain or bowel obstruction.
• Deep vein thrombosis or pulmonary embolism.

Long‑Term Complications (If not addressed)

• Early osteoporosis – up to 30 % increased fracture risk within 10 years (Mayo Clinic, 2021).
• Cardiovascular disease – earlier onset of hypertension and atherosclerosis.
• Cognitive decline – meta‑analysis links surgical menopause before age 45 with a 1.5‑fold higher risk of dementia.
• Sexual dysfunction – persistent vaginal atrophy and decreased libido.
• Psychological impact – depression, anxiety, and decreased quality of life in up to 20 % of women if not supported.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, American College of Obstetricians and Gynecologists (ACOG), peer‑reviewed oncology journals (2022‑2024).

```